We are live on ! Find out more
NHC

Nicholas Hoffman & Company Portfolio holdings

AUM $4.33B
1-Year Est. Return 18.98%
This Fund
S&P 500
This Quarter Est. Return
+1.61%
1 Year Est. Return
+18.98%
3 Year Est. Return
+55.21%
5 Year Est. Return
+46.72%
10 Year Est. Return
+185.29%
AUM
$2.13B
AUM Growth
+$162M
Cap. Flow
+$135M
Cap. Flow %
6.32%
Top 10 Hldgs %
74.03%
Holding
303
New
12
Increased
145
Reduced
81
Closed
18

Top Sells

Rank Stock Value
1
ACN icon
Accenture
ACN
+$1.04M
2
CVS icon
CVS Health
CVS
+$650K
3
CIVB icon
Civista Bancshares
CIVB
+$555K
4
MMM icon
3M
MMM
+$392K
5
UL icon
Unilever
UL
+$357K

Sector Composition

Rank Sector Weight
1 Technology 7.84%
2 Financials 7.12%
3 Consumer Staples 1.93%
4 Healthcare 1.77%
5 Consumer Discretionary 1.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ILF icon
76
iShares Latin America 40 ETF
ILF
$3.79B
$1.64M 0.08%
66,235
+4,074
+7% +$110K
RTX icon
77
RTX Corp
RTX
$295B
$1.62M 0.08%
16,171
+319
+2% +$33K
GSK icon
78
GSK
GSK
$108B
$1.6M 0.07%
41,487
-7
-0% -$294
KMB icon
79
Kimberly-Clark
KMB
$37.5B
$1.59M 0.07%
11,506
-233
-2% -$31.1K
CSCO icon
80
Cisco
CSCO
$456B
$1.57M 0.07%
33,011
+837
+3% +$39.7K
DFUS
81
Dimensional US Equity ETF
DFUS
$20.7B
$1.56M 0.07%
26,502
+2
+0% +$114
MO icon
82
Altria Group
MO
$125B
$1.55M 0.07%
34,103
+5,294
+18% +$235K
VIGI icon
83
Vanguard International Dividend Appreciation ETF
VIGI
$9.04B
$1.54M 0.07%
18,978
+3,655
+24% +$293K
SCHB icon
84
Schwab US Broad Market ETF
SCHB
$42.9B
$1.49M 0.07%
70,869
+810
+1% +$16.4K
SCHW
85
Charles Schwab
SCHW
$184B
$1.48M 0.07%
20,096
-415
-2% -$30.7K
SSB icon
86
SouthState Bank Corp
SSB
$10.3B
$1.47M 0.07%
19,259
+123
+0.6% +$9.53K
GPC icon
87
Genuine Parts
GPC
$17.9B
$1.46M 0.07%
10,565
+1
+0% +$149
MDLZ icon
88
Mondelez International
MDLZ
$80.2B
$1.46M 0.07%
22,308
+3,328
+18% +$228K
SGOV icon
89
iShares 0-3 Month Treasury Bond ETF
SGOV
$99.3B
$1.43M 0.07%
14,155
-561
-4% -$56.4K
CL icon
90
Colgate-Palmolive
CL
$74.2B
$1.41M 0.07%
14,537
+3
+0% +$277
EFV icon
91
iShares MSCI EAFE Value ETF
EFV
$28.4B
$1.39M 0.07%
26,143
+79
+0.3% +$4.29K
PEP icon
92
PepsiCo
PEP
$195B
$1.38M 0.06%
8,358
+1
+0% +$173
TTE icon
93
TotalEnergies
TTE
$187B
$1.37M 0.06%
20,523
-179
-0.9% -$12.7K
LMT icon
94
Lockheed Martin
LMT
$134B
$1.36M 0.06%
2,919
+32
+1% +$14.8K
SYK icon
95
Stryker
SYK
$133B
$1.34M 0.06%
3,951
-226
-5% -$76.6K
BMY icon
96
Bristol-Myers Squibb
BMY
$130B
$1.33M 0.06%
32,049
-843
-3% -$37.7K
ABBV icon
97
AbbVie
ABBV
$465B
$1.31M 0.06%
7,665
+4
+0.1% +$663
NOC icon
98
Northrop Grumman
NOC
$78B
$1.29M 0.06%
2,963
+2
+0.1% +$913
SCHA icon
99
Schwab U.S Small- Cap ETF
SCHA
$22.2B
$1.29M 0.06%
54,180
+60
+0.1% +$1.42K
SNY icon
100
Sanofi
SNY
$109B
$1.25M 0.06%
25,696
-37
-0.1% -$1.78K

Similar funds

Nicholas Hoffman & Company's Q2 2024 Portfolio in Review

As of Q2 2024, Nicholas Hoffman & Company held 303 positions worth $2.13B, up 8.2% from $1.97B the previous quarter. Its ten largest holdings account for 74% of the portfolio.

Nicholas Hoffman & Company deployed $135M of net new capital in Q2 2024, opening 12 new positions and adding to 145 existing holdings. Its largest new stake was iShares Russell 1000 Growth ETF: 7,808 shares worth $712K.

By sector, the portfolio is most concentrated in Technology at 7.8% of assets, up from 7.7% a quarter earlier, followed by Financials and Consumer Staples.

On the sell side, the largest reduction was Accenture, an estimated $1.04M trimmed.

  • Nicholas Hoffman & Company's largest Q2 2024 buy was iShares Russell 1000 Growth ETF: 7,808 shares worth $712K.
  • Nicholas Hoffman & Company added most to Vanguard FTSE Developed Markets ETF in Q2 2024, an estimated $41.8M increase.
  • Nicholas Hoffman & Company's biggest Q2 2024 reduction was Accenture, cutting an estimated $1.04M.
  • Nicholas Hoffman & Company fully exited CVS Health in Q2 2024, selling an estimated $650K.
  • Nicholas Hoffman & Company's ten largest holdings make up 74% of its $2.13B portfolio in Q2 2024.
  • Nicholas Hoffman & Company opened 12 new positions and closed 18 in Q2 2024.
  • Nicholas Hoffman & Company's portfolio value rose 8.2% quarter-over-quarter to $2.13B.

Based on Nicholas Hoffman & Company's 13F filing for Q2 2024, filed 2 Aug 2024.